KARD vs LBRX: stock comparison and AI forecast
Kardigan, Inc. (KARD) and Lb Pharmaceuticals Inc (LBRX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KARD Kardigan, Inc.
- Market Cap
- $1.30B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
LBRX Lb Pharmaceuticals Inc
- Market Cap
- $1.23B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- KARD and LBRX have similar market capitalizations ($1.30B and $1.23B).
- KARD carries 0.17 times debt per unit of equity, against 0.09 times for LBRX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KARD | LBRX |
|---|---|---|
| Market Cap | $1.30B | $1.23B |
| P/B Ratio | 2.11x | 2.94x |
| EPS | – | $-6.73 |
| Book Value/Share | $6.58 | $12.95 |
| FCF/Share | – | $-4.46 |
Profitability & Margins
| Metric | KARD | LBRX |
|---|---|---|
| ROE | – | -36.2% |
| ROA | – | -33.4% |
| Tax Rate | – | 0.0% |
Financial Health
| Metric | KARD | LBRX |
|---|---|---|
| Current Ratio | 8.72x | 14.78x |
| D/E Ratio | 0.17x | 0.09x |
| Financial Leverage | 1.17x | 1.09x |
| Working Capital | $540M | $417M |
Cash Flow
| Metric | KARD | LBRX |
|---|---|---|
| Operating Cash Flow | – | -$143M |
| Free Cash Flow | – | -$144M |
| Capital Spending | – | -$510K |
Income Statement
| Metric | KARD | LBRX |
|---|---|---|
| Net Income | – | -$151M |
| R&D Expense | – | $125M |
Dividend & Shareholder Information
| Metric | KARD | LBRX |
|---|---|---|
| Shares Outstanding | 94M | 32M |
KARD vs LBRX: stock comparison and AI forecast
Which is bigger, KARD or LBRX?
KARD and LBRX have similar market capitalizations ($1.30B and $1.23B).
Which one does Intratio's AI model rank higher, KARD or LBRX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.